MoneyWorks4Me

Medicamen Biotech informs about disclosure

23 Mar 2024 Evaluate

Medicamen Biotech has informed that it enclosed disclosure under regulation 29(2) of SAST Regulations, 2011 received from Growel Remedies for sale of 200000 Equity Shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..